The world's oldest pharmaceutical and chemicals’ company Merck on Friday announced the expansion of its M Lab Collaboration Center here.
The facility will provide biopharmaceutical manufacturers with a shared, exploratory environment where they can collaborate with Merck scientists and engineers to solve their challenges and accelerate development of new therapies.
The expanded centre leverages Merck’s technical and application expertise. It includes a simulated manufacturing environment and enables collaboration with Merck experts to evaluate processes and accelerates development and production of new therapies. In addition, education on best practices and new approaches to develop, optimise and scale-up processes and ways to simplify global technology transfer will be available to customers.
“Bangalore is a hub for India’s rapidly growing biopharmaceutical manufacturing industry,” said Udit Batra, Member of the Merck Executive Board and CEO, Life Science. “With the expansion of our M Lab™ Collaboration Center in Bangalore, we are providing customers with hands-on experience and customised support required to optimise their manufacturing processes to quickly bring the much-needed therapies to patients.”
The new M Lab™ Collaboration Center is one of nine such centres around the world. Each centre helps customers, government collaborators, academia, regulatory bodies and industry associations to increase their productivity, mitigate risk and improve processes with the help of an industry-leading team of Merck experts. Customers have access to sizing and simulation tools and methodologies, analytical and modelling support, training sessions and educational programs.